My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    The Edinburgh Type 2 Diabetes Study: study protocol.

    Price JF, Reynolds RM, Mitchell RJ, Williamson RM, Fowkes FG, Deary IJ, Lee AJ, Frier BM, Hayes PC, Strachan MW.

    BMC Endocr Disord. 2008 Dec 11;8:18.PMID: 19077235 [PubMed]Related articlesFree article

    2.

    Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

    [No authors listed]

    Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

    Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J; LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health).

    Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. Review.PMID: 11258203 [PubMed - indexed for MEDLINE]Related articles

    5.

    Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

    Marioni RE, Strachan MW, Reynolds R, Lowe GD, Mitchell RJ, Fowkes FG, Frier BM, Lee AJ, Butcher I, Rumley A, Murray GD, Deary IJ, Price JF.

    Diabetes. 2009 Dec 3. [Epub ahead of print]PMID: 19959761 [PubMed - as supplied by publisher]Related articles

    6.

    Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease.

    Mustonen J, Uusitupa M, Mäntysaari M, Länsimies E, Pyörälä K, Laakso M.

    J Intern Med. 1997 Mar;241(3):227-35.PMID: 9104436 [PubMed - indexed for MEDLINE]Related articles

    7.

    Oral antidiabetic agents: current role in type 2 diabetes mellitus.

    Krentz AJ, Bailey CJ.

    Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

    Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

    Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.PMID: 16961167 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units.

    Caballería L, Auladell MA, Torán P, Miranda D, Aznar J, Pera G, Gil D, Muñoz L, Planas J, Canut S, Bernad J, Aubà J, Pizarro G, Aizpurua MM, Altaba A, Tibau A.

    BMC Gastroenterol. 2007 Nov 5;7:41.PMID: 17983472 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study.

    Caballería L, Auladell MA, Torán P, Pera G, Miranda D, Alumà A, Casas JD, Muñoz L, Sanchez C, Tibau A, Birules M, Canut S, Bernad J, Aubà J, Aizpurua MM, Alcaraz E.

    BMC Gastroenterol. 2008 Oct 3;8:44.PMID: 18831772 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

    André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E.

    Diabetes Metab. 2005 Dec;31(6):542-50.PMID: 16357802 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

    Krentz AJ.

    Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.PMID: 14984018 [PubMed - indexed for MEDLINE]Related articles

    13.

    The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond.

    Deary IJ, Gow AJ, Taylor MD, Corley J, Brett C, Wilson V, Campbell H, Whalley LJ, Visscher PM, Porteous DJ, Starr JM.

    BMC Geriatr. 2007 Dec 5;7:28. Review.PMID: 18053258 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study.

    Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J.

    Diabetologia. 2000 Feb;43(2):156-64.PMID: 10753036 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

    Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

    Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

    [No authors listed]

    Diabetes. 1999 Feb;48(2):383-90.PMID: 10334318 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project.

    Monastero R, Palmer K, Qiu C, Winblad B, Fratiglioni L.

    Am J Geriatr Psychiatry. 2007 Jan;15(1):60-9.PMID: 17194816 [PubMed - indexed for MEDLINE]Related articles

    18.

    Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

    Plosker GL, Figgitt DP.

    Pharmacoeconomics. 2004;22(6):389-411. Review.PMID: 15099124 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study.

    Gallacher JE, Pickering J, Elwood PC, Bayer AJ, Yarnell JW, Ben-Shlomo Y.

    Eur J Epidemiol. 2005;20(9):761-8.PMID: 16170659 [PubMed - indexed for MEDLINE]Related articles

    20.

    Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men.

    Strandberg TE, Salomaa V.

    Nutr Metab Cardiovasc Dis. 2000 Oct;10(5):239-46.PMID: 11213532 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity